Shuttle Pharmaceuticals Holdings (SHPH) Net Equity Issued and Repurchased (2022 - 2026)

Shuttle Pharmaceuticals Holdings' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased fell 40.38% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $8.6 million, a N/A change from a year earlier, with the FY2024 full-year figure at $4.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased retreated to $3.2 million in Q1 2026 per SHPH's latest filing, from $5.4 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $5.4 million in Q1 2025 and bottomed at -$23320.0 in Q4 2022.
• The 3-year median for Net Equity Issued and Repurchased is $3.2 million (2026), against an average of $2.9 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 40.38% in 2026; the steepest drop was 40.38% in 2026.
• Year by year, Net Equity Issued and Repurchased stood at -$23320.0 in 2022, then surged by 23297.57% to $5.4 million in 2025, then plunged by 40.38% to $3.2 million in 2026.
• Per Business Quant, the three latest SHPH Net Equity Issued and Repurchased figures stand at $3.2 million (Q1 2026), $5.4 million (Q1 2025), and -$23320.0 (Q4 2022).